Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.39
-0.02
(-0.59%)
USD |
NASDAQ |
Nov 13, 16:00
3.46
+0.07
(+2.06%)
After-Hours: 19:59
Corbus Pharmaceuticals Holdings Enterprise Value : -41.57M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | -41.57M |
| November 12, 2026 | -41.16M |
| November 11, 2026 | -29.00M |
| November 10, 2026 | -30.44M |
| November 09, 2026 | -38.89M |
| November 06, 2026 | -48.17M |
| November 05, 2026 | -52.49M |
| November 04, 2026 | -37.86M |
| November 03, 2026 | -31.68M |
| November 02, 2026 | -30.75M |
| October 30, 2026 | -24.47M |
| October 29, 2026 | -24.47M |
| October 28, 2026 | -23.85M |
| October 27, 2026 | -25.91M |
| October 26, 2026 | -29.21M |
| October 23, 2026 | -27.97M |
| October 22, 2026 | -26.32M |
| October 21, 2026 | -23.13M |
| October 20, 2026 | -20.35M |
| October 19, 2026 | -19.52M |
| October 16, 2026 | -18.29M |
| October 15, 2026 | -22.20M |
| October 14, 2026 | -20.55M |
| October 13, 2026 | -12.93M |
| October 12, 2026 | -2.830M |
| Date | Value |
|---|---|
| October 09, 2026 | -0.5634M |
| October 08, 2026 | -2.830M |
| October 07, 2026 | 1.703M |
| October 06, 2026 | 7.679M |
| October 05, 2026 | 9.122M |
| October 02, 2026 | 14.89M |
| October 01, 2026 | 19.22M |
| September 30, 2026 | 29.11M |
| September 29, 2026 | 10.12M |
| September 28, 2026 | 15.53M |
| September 25, 2026 | 19.64M |
| September 24, 2026 | 25.43M |
| September 23, 2026 | 30.84M |
| September 22, 2026 | 33.36M |
| September 21, 2026 | 29.16M |
| September 18, 2026 | 25.99M |
| September 17, 2026 | 21.88M |
| September 16, 2026 | 21.88M |
| September 15, 2026 | 15.53M |
| September 14, 2026 | 37.19M |
| September 11, 2026 | 37.94M |
| September 10, 2026 | 40.18M |
| September 09, 2026 | 51.75M |
| September 08, 2026 | 84.15M |
| September 04, 2026 | 93.20M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Heron Therapeutics, Inc. | 168.30M |
| Tonix Pharmaceuticals Holding Corp. | -103.90M |
| Karyopharm Therapeutics, Inc. | 191.66M |
| Minerva Neurosciences, Inc. | 109.32M |
| Ocugen, Inc. | 285.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -37.75M |
| Total Expenses (Quarterly) | 37.75M |
| EPS Diluted (Quarterly) | -1.812 |
| Earnings Yield | -179.7% |
| Normalized Earnings Yield | -179.70 |